Advanced and automated innovation labs for diagnostic and therapeutic biopharma solutions


22 Sept.			16:00 - 17:30


TT.XII - Technical Multi-Track with Parallel SYMPOSIA
Session Flagship Project FP7: Advanced and automated innovation labs for diagnostic and therapeutic biopharma solutions
Lead industry: Takis, Catalent Anagni Universities and EPR: Università La Sapienza, Università di Roma Tor Vergata, Università degli studi Roma Tre, Università della Tuscia, Università Campus Bio-Medico di Roma, CNR, INFN, ISS
Chairs: Augusto GIARDINI, OPEX and PMO Director Catalent Anagni & Cristina LIMATOLA, Sapienza University of Rome
FP7 is aimed to contribute to the development of an advanced open innovation Joint Laboratory focused on the accelerated development of biopharma solutions for enabling innovative characterization and large-scale production of high-affinity monoclonal antibodies for diagnostic and therapeutic applications, and other emerging solutions for relevant pathologies. This laboratory will be directly shared as Joint Open Lab with the research partners of Rome Technopole specialized on the specific area of bio-pharma and with all the other interested Rome Technopole partners and stakeholders for technology transfer, innovation and training activities.
The symposium is part of the Special event SE.II
TT.XII.D.0 SE.II.8.0	Introduction by the Chairs
TT.XII.D.1 SE.II.8.1	Raffaele SALADINO University of Tuscia A unique and integrated lignin based nano-platform for health and nanomedicine applications
TT.XII.D.2 SE.II.8.2	Lucia GABRIELE ISS Establishing ISoChipLab to develop immune_system-on-chip models for improving preclinical research and drug testing
TT.XII.D.3 SE.II.8.3	Alberto SINIBALDI - CV Sapienza University of Rome Development of a point-of-care nano-photonic platform for the quantitative detection of biomarkers in plasma of patients affected by cancer and infectious diseases
TT.XII.D.4 SE.II.8.4	Eliana CAPECCHI University of studies of Tuscia Sustainable Nanostructured Polyphenols: advanced Bio-Inks and biosensors for dermocosmetic and precision medicine
TT.XII.D.5 SE.II.8.5	Federica MONDIO e Augusto GIARDINI Catalent Anagni Srl Lipidic Nano Particles and their use in the m-RNA vaccines